Springer Nature
Browse
12933_2024_2309_MOESM1_ESM.pdf (177.84 kB)

Additional file 1 of Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

Download (177.84 kB)
journal contribution
posted on 2024-06-29, 04:22 authored by Shinya Fujiki, Kenichi Iijima, Yoshihisa Nakagawa, Kazuyoshi Takahashi, Masaaki Okabe, Kengo Kusano, Shingen Owada, Yusuke Kondo, Kenichi Tsujita, Wataru Shimizu, Hirofumi Tomita, Masaya Watanabe, Morio Shoda, Masafumi Watanabe, Takashi Tokano, Toyoaki Murohara, Takashi Kaneshiro, Takeshi Kato, Hidemori Hayashi, Koji Maemura, Shinichi Niwano, Tomio Umemoto, Hisako Yoshida, Keiko Ota, Takahiro Tanaka, Nobutaka Kitamura, Koichi Node, Tohru Minamino
Supplementary Material 1.

Funding

Nippon Boehringer Ingelheim Co. Ltd. and Eli Lilly and Company AMED-CREST Moonshot Research and Development Program

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    Ventricular arrhythmiaSodium-glucose cotransporter 2Type 2 diabetesEmpagliflozin

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC